Kahlert UD - Search Results

1

Inflammatory Signals Across the Spectrum: A Detailed Exploration of Acute Appendicitis Stages According to EAES 2015 Guidelines.

Dölling M, Andric M, Rahimli M, Klös M, Pachmann J, Stockheim J, Al-Madhi S, Wex C, Kahlert UD, Herrmann M, Perrakis A, Croner RS. Dölling M, et al. Among authors: kahlert ud. Diagnostics (Basel). 2024 Oct 21;14(20):2335. doi: 10.3390/diagnostics14202335. Diagnostics (Basel). 2024. PMID: 39451658 Free PMC article.

2

Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis.

Dölling M, Rahimli M, Pachmann J, Szep M, Al-Madhi S, Andric M, Kahlert UD, Hofmann T, Boettcher M, Muñoz LE, Herrmann M, Perrakis A, Croner RS. Dölling M, et al. Among authors: kahlert ud. J Clin Med. 2024 Jul 16;13(14):4166. doi: 10.3390/jcm13144166. J Clin Med. 2024. PMID: 39064205 Free PMC article.

3

Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.

Shi W, Li C, Wartmann T, Kahlert C, Du R, Perrakis A, Brunner T, Croner RS, Kahlert UD. Shi W, et al. Among authors: kahlert ud, kahlert c. J Pers Med. 2022 Mar 16;12(3):478. doi: 10.3390/jpm12030478. J Pers Med. 2022. PMID: 35330477 Free PMC article.

4

COL10A1 allows stratification of invasiveness of colon cancer and associates to extracellular matrix and immune cell enrichment in the tumor parenchyma.

Kahlert UD, Shi W, Strecker M, Scherpinski LA, Wartmann T, Dölling M, Perrakis A, Relja B, Mengoni M, Braun A, Croner RS. Kahlert UD, et al. Front Oncol. 2022 Oct 4;12:1007514. doi: 10.3389/fonc.2022.1007514. eCollection 2022. Front Oncol. 2022. PMID: 36267978 Free PMC article.

5

Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.

Shi W, Wartmann T, Accuffi S, Al-Madhi S, Perrakis A, Kahlert C, Link A, Venerito M, Keitel-Anselmino V, Bruns C, Croner RS, Zhao Y, Kahlert UD. Shi W, et al. Among authors: kahlert ud, kahlert c. Br J Cancer. 2024 Jan;130(1):125-134. doi: 10.1038/s41416-023-02488-4. Epub 2023 Nov 10. Br J Cancer. 2024. PMID: 37950093 Free PMC article.

6

Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning.

Wurm LM, Fischer B, Neuschmelting V, Reinecke D, Fischer I, Croner RS, Goldbrunner R, Hacker MC, Dybaś J, Kahlert UD. Wurm LM, et al. Among authors: kahlert ud. Analyst. 2023 Nov 20;148(23):6109-6119. doi: 10.1039/d3an01303k. Analyst. 2023. PMID: 37927114

7

Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo.

Du R, Sanin AY, Shi W, Huang B, Nickel AC, Vargas-Toscano A, Huo S, Nickl-Jockschat T, Dumitru CA, Hu W, Duan S, Sandalcioglu IE, Croner RS, Alcaniz J, Walther W, Berndt C, Kahlert UD. Du R, et al. Among authors: kahlert ud. Front Pharmacol. 2024 Sep 25;15:1468920. doi: 10.3389/fphar.2024.1468920. eCollection 2024. Front Pharmacol. 2024. PMID: 39386028 Free PMC article.

8

Canonical WNT pathway inhibition reduces ATP synthesis rates in glioblastoma stem cells.

Ouwens DM, Hewera M, Li G, Di W, Muhammad S, Hänggi D, Steiger HJ, Dumitru CA, Sandalcioglu E, Croner RS, Zhang W, Kakhlon O, Kahlert UD. Ouwens DM, et al. Among authors: kahlert ud. Front Biosci (Landmark Ed). 2022 Jan 18;27(1):35. doi: 10.31083/j.fbl2701035. Front Biosci (Landmark Ed). 2022. PMID: 35090340 Free article.

9

Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology.

Uhlmann C, Nickel AC, Picard D, Rossi A, Li G, Hildebrandt B, Brockerhoff G, Bendt F, Hübenthal U, Hewera M, Steiger HJ, Wieczorek D, Perrakis A, Zhang W, Remke M, Koch K, Tigges J, Croner RS, Fritsche E, Kahlert UD. Uhlmann C, et al. Among authors: kahlert ud. Biotechnol J. 2022 Jun;17(6):e2100693. doi: 10.1002/biot.202100693. Epub 2022 Apr 3. Biotechnol J. 2022. PMID: 35334498

10

In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells.

Knauer N, Arkhipova V, Li G, Hewera M, Pashkina E, Nguyen PH, Meschaninova M, Kozlov V, Zhang W, Croner RS, Caminade AM, Majoral JP, Apartsin EK, Kahlert UD. Knauer N, et al. Among authors: kahlert ud. Int J Mol Sci. 2022 May 19;23(10):5691. doi: 10.3390/ijms23105691. Int J Mol Sci. 2022. PMID: 35628503 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters